促进肯尼亚和乌干达HIV感染高风险成人频繁检测的行为干预巨型研究:随机对照试验方案
该方案计划在肯尼亚西部和乌干达西南部开展12臂随机对照试验,纳入30000至40000名自报HIV感染风险增加且拥有手机的≥15岁HIV未感染成人。参与者在基线HIV阴性检测后随机分配至10种低成本行为助推干预、1种经济激励干预或标准护理对照组,主要结局为基线检测后3至6个月内在任一研究场所进行HIV复检。
要点
- WHO指南建议高风险成人每3至6个月复检HIV,但撒哈拉以南非洲定期复检不频繁。
- 巨型研究可同时评估多种行为干预,快速识别行为解决方案并克服跨独立试验比较的挑战。
- 试验将测量HIV阳性率、关怀链接与ART启动及PrEP转介接受情况。
核心结论
- 该方案将同时测试多种低成本行为干预,以增加肯尼亚和乌干达HIV感染高风险成人的HIV复检。
研究设计与样本
- 在肯尼亚西部和乌干达西南部开展12臂随机对照试验,纳入30000至40000名自报HIV感染风险增加且拥有手机的≥15岁HIV未感染成人。
- 参与者在高流量HIV检测中心基线HIV阴性检测后,个体随机平行分配至12臂之一:10种低成本助推信息干预、1种复检经济激励干预或1个标准护理对照组。
主要发现
- 主要结局为初始基线HIV检测后3至6个月内在任一研究场所进行HIV复检。
- 还将测量随访时的HIV阳性率、关怀链接与ART启动及PrEP转介接受情况。
关键数值与推荐
- WHO指南建议感染风险增加的成人每3至6个月复检HIV。
临床怎么用
- 研究方法和结果将为HIV服务提供者提供见解,并影响研究者和项目设计及测试低成本、可扩展的促进健康行为干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Frequent HIV testing among people at high risk of HIV infection is critical for early diagnosis and prompt antiretroviral therapy (ART) initiation for those who test HIV positive, as well as provision of effective biomedical HIV prevention modalities like pre-exposure prophylaxis (PrEP) for those who test negative. Despite World Health Organization (WHO) guidelines recommending retesting for HIV every 3-6 months for adults at increased risk, regular retesting is infrequent in sub-Saharan Africa. Large-scale, multi-arm field experiments ("megastudies") can evaluate many different behavioral interventions among the same population and at the same time rapidly identify behavioral solutions and overcome the challenge of comparing results across standalone trials. We describe the protocol for a megastudy that will simultaneously test multiple low-cost behavioral interventions to increase HIV retesting among adults at high risk of HIV infection in rural Kenya and Uganda. METHODS: We will conduct a 12-arm randomized trial of light-touch ("nudge") behavioral interventions among 30,000-40,000 HIV-uninfected adults aged ≥ 15 years in western Kenya and southwestern Uganda who self-report increased risk of HIV infection and have access to a mobile phone. Following a baseline HIV-negative test at a high-volume HIV testing center, participants will be individually randomized in parallel to one of 12 arms, including 10 different intervention arms comprising low-cost messages that serve as nudges for retesting, an intervention arm with a financial incentive for retesting, or a control arm with standard of care post-test counseling services. The primary outcome will be HIV retesting at any study venue 3-6 months after the initial baseline HIV test. We will also measure HIV-positivity, linkage to care and ART initiation, and PrEP referral acceptance at follow-up. DISCUSSION: This study will provide new information on low-cost interventions to promote HIV retesting for adults at elevated risk of infection in East Africa. The methods and results of this study will provide valuable insights for those engaged in HIV service delivery and influence how researchers and programs design and test low-cost, scalable interventions to promote health behaviors. TRIAL REGISTRATION: ClinicalTrials.gov NCT06971367. Registered on May 6, 2025, https://clinicaltrials.gov/study/NCT06971367.
引用
- Marson K, Kabami J, Buttenheim AM, et al. A megastudy of behavioral interventions to promote frequent HIV testing among adults at high risk of HIV infection in Kenya and Uganda: study protocol for a randomized controlled trial. Trials. 2026. PMID: 42163283. doi:10.1186/s13063-026-09783-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。